This mutation causes the resistance of Factor V to the proteolysis by the APC. It accounts for 90% to 95% of cases of APC resistance and it has an incidence of 4.8% in the general population. [29] FVL seems to play a role in arterial thrombosis and in its complication such as myocardial infarction, [30] but the data available in literature do not